Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Strategic Review = Debt+
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by visionaryfoolon Oct 12, 2016 10:29am
58 Views
Post# 25334612

RE:RE:Strategic Review = Debt+

RE:RE:Strategic Review = Debt+10 shares...? what does "hold 10/15 inventory allocation" mean?

PROtrading wrote:
Contra_Man wrote: Adding ten (10) T.CXR positions @ $5.95 to hold 10/15 inventory allocation.


For the record. For those who don't know this contrarian trader, this sheep with boots and hat is actually quite good.  Went long last week but he doesn't do any fundamentals it seems.  He is purely a contrarian TA player.

Same category of trader as our craigbbad here but different styles.



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities